Publication | Closed Access

Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors

Oncogenic AgentMedicinePharmacologyCancer Cell BiologyTumor SuppressorCancer BiologyCell BiologyTumor BiologyOvarian Cancer